Re: chemical structure and stability of gadolinium chelates.
Idée
Jean-Marc
JM
Port
Marc
M
Corot
Claire
C
D002614:Chelating Agents / Q000009:adverse effects / Q000737:chemistry; D003287:Contrast Media / Q000009:adverse effects; D005682:Gadolinium / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects*; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced* / Q000517:prevention & control*; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D017751:Safety Management
D002614:Chelating Agents; D003287:Contrast Media; D005682:Gadolinium